GLP-1 drugs show promise for weight management Across the reviews, tirzepatide, semaglutide, and liraglutide each led to significant weight loss compared to placebo after one to two years, with these effects likely to be sustained while treatment continues
And I just want to say that the parallels here, for example, with Kati Karik , my friend who had the Nobel Award for mRNA, she spent three decades trying to get people to listen to her and never got a grant from the NIH or other places [our conversation here]
Exendin-phe1 outperforms other GLP-1R agonists We next compared the pharmacological characteristics and beta cell actions of exendin-phe1 with those of other clinically approved GLP-1R agonists, including Lixisenatide, Liraglutide, Semaglutide, and Dulaglutide
In patients with T2D, GLP-1RA were associated with a 21% reduction in composite kidney outcomes mostly driven by amelioration of albuminuria 80
Diabetes (1990) 39:7526
Not significantly but there are a few situations to note: Delayed stomach emptying GLP-1 medications slow digestion
